The end of the year brings noise. Your membership ensures our newsroom remains a clear, reliable source of facts for the whole community. Help us keep the signal strong for the year ahead.
Already a member? Log in to hide these messages.
The end of the year brings noise. Your membership ensures our newsroom remains a clear, reliable source of facts for the whole community. Help us keep the signal strong for the year ahead.
Already a member? Log in to hide these messages.
Marty Makary, the head of the Food and Drug Administration, is under fire from both ends of the ideological spectrum for reportedly pushing back the highly contested safety review of the abortion pill mifepristone.
